To understand the potential role of the upregulated SHP-2 in mediating the activation of T2DM monocytes, we pharmacologically inhibited SHP-2 and analysed the chemokinesis of monocytes as the readout of monocyte activation. The gene discussed is PTPN11; the disease is type 2 diabetes mellitus.